top of page

RESEARCH IN FOCUS

Explore OPRI’s collection of published research on Oral Corticosteroid (OCS) use

PUBLICATIONS DATABASE

Identifying patient attitudinal clusters associated with asthma control: the European REALISE survey

Journal of Allergy and Clinical Immunology: In Practice

19 November 2017

Thys van der Molen, Monica Fletcher, David Price

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

International Journal of Chronic Obstructive Pulmonary Disease

3 November 2017

Sinthia Bosnic-Anticevich, Henry Chrystyn, Richard Costello, Myrna B Dolovich, Monica Fletcher, Federico Lavorini, Roberto Rodríguez-Roisin, Dermot Ryan, Simon Wan Yau Ming, David Price

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial

The Lancet Respiratory Medicine

3 November 2017

David Price, Roland Buhl, Adrian Chan, Daryl Freeman, Elizabeth Gardener, Clifford Godley, Kevin Gruffyd-Jones, Lorcan McGarvey, Ken Ohta, Dermot Ryan, Jörgen Syk, Ngiap Chuan Tan, Tze Lee Tan, Mike Thomas, Sen Yang, Priyanka Raju Konduru, Marcus Ngantcha, Martina Stagno d’Alcontres, Therese S Lapperre

Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases

J Asthma Allergy

5 September 2017

Peter Smith, David Price, Harvey R, Carney AS, Kritikos V, Sinthia Bosnic-Anticevich, Christian L, Derek Skinner, Victoria Carter, Alice MS Durieux

Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed dose combination therapy in Australia

Journal of Asthma

5 September 2017

Sinthia Bosnic-Anticevich, Kritikos V, Victoria Carter, Yan KY, Armour C, Dermot Ryan, David Price

Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study

Pragmatic and Observational Research

30 August 2017

Carney AS, David Price, Peter Smith, Richard Harvey, Vicky Kritikos, Sinthia Bosnic-Anticevich, Louise Christian, Derek Skinner, Victoria Carter, Alice MS Durieux

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study

International Journal of Chronic Obstructive Pulmonary Disease

17 August 2017

Rupert Jones, Jessica Martin, Vicky Thomas, Derek Skinner, Jonathan Marshall, Martina Stagno d’Alcontres, David Price

Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes

Journal of Allergy and Clinical Immunology: In Practice

1 August 2017

David Price, Miguel Román Rodríguez, R. Brett McQueen, Sinthia Bosnic-Anticevich, Victoria Carter, Kevin Gruffyd-Jones, John Haughney, Svein Høegh Henrichsen, Catherine Hutton, Antonio Infantino, Federico Lavorini, Lisa M Law, Karin Lisspers, Alberto Papi, Dermot Ryan, Björn Ställberg, Thys van der Molen, Henry Chrystyn

Full Text

Blood eosinophil count and exacerbation risk in patients with COPD

European Respiratory Journal

20 July 2017

Marjan Kerkhof, Samatha Sonnappa, Dirkje Postma, Guy Brusselle, Alvar Agustí, Antonio Anzueto, Rupert Jones, Alberto Papi, Ian Pavord, Emilio Pizzichini, Todor Popov, Nicolas Roche, Dermot Ryan, Mike Thomas, Claus Vogelmeier, Alison Chisholm, Daryl Freeman, Mona Bafadhel, Elizabeth V Hillyer, David Price

Impact of spacers on therapeutic ratio with inhaled corticosteroids

Journal of Allergy and Clinical Immunology: In Practice

1 July 2017

Theresa W Guilbert, David Price

Pub Med

Initiating or changing to a fixed-dose combination of fluticasone propionate/formoterol over fluticasone propionate/salmeterol: a real-life effectiveness and cost impact evaluation

Respiratory Medicine

24 June 2017

Simon Wan Yau Ming, John Haughney, Iain Small, Stephanie Wolfe, John Hamill, Kevin Gruffyd-Jones, Cathal Daly, Joan B. Soriano, Elizabeth Gardener, Derek Skinner, Martina Stagno d’Alcontres, David Price

Risk of pneumonia in obstructive lung disease: a real-life study comparing extra-fine and fine-particle inhaled corticosteroids

PLOS ONE

15 June 2017

Samatha Sonnappa, Richard J Martin, Elliot Israel, Dirkje Postma, Willem M.C. van Aalderen, Annie Burden, David Price, Omar S. Usmani

Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database

Pragmatic and Observational Research

18 May 2017

David Price, Eran Gefen, Gokul Gopalan, Cristiana Miglio, Rosie McDonald, Vicky Thomas, Simon Wan Yau Ming

Ipratropium/Salbutamol comparator versus originator for chronic obstructive pulmonary disease exacerbations: US observational cohort study using the Clinformatics™ health claims database

Pulmonary Therapy

24 April 2017

Vicky Thomas, Eran Gefen, Gokul Gopalan, Rafael Mares, Rosie McDonald, Simon Wan Yau Ming, David Price

Pub Med

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

Pragmatic and Observational Research

18 April 2017

Jaco Voorham, Bernard Vrijens, Job F.M. van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law, David Price

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

Clinical Epidemiology

17 April 2017

Jens Dollerup, Jørgen Vestbo, Tarita Murray-Thomas, Alan Kaplan, Richard J Martin, Emilio Pizzichini, Marcia M M Pizzichini, Annie Burden, Jessica Martin, David Price

Cohort analysis of exacerbation rates in adolescent and adult patients initiating inhaled corticosteroids for asthma: different dose-response profile by particle size

Pulmonary Therapy

12 April 2017

Dirkje Postma, Alan Kaplan, Joan B. Soriano, Jonathon Grigg, Theresa W Guilbert, Willem M.C. van Aalderen, Nicolas Roche, Annie Burden, Elizabeth V Hillyer, Elliot Israel, David Price

Pub Med

A randomized pragmatic trial of changing to and stepping down fluticasone/formoterol in asthma

Journal of Allergy and Clinical Immunology: In Practice

25 March 2017

Omar S. Usmani, Anu Kemppinen, Elizabeth Gardener, Vicky Thomas, Priyanka Raju Konduru, Christina Callan, Andrew McLoughlin, Vanessa Woodhead, Adam Brady, Elizabeth F Juniper, Peter J Barnes, David Price

Comparative effectiveness of step-up therapies in children with asthma prescribed inhaled corticosteroids: a historical cohort study

Journal of Allergy and Clinical Immunology: In Practice

25 March 2017

Clare Murray, Mike Thomas, Kathryn Richardson, David Price, Steve Turner

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

Pragmatic and Observational Research

22 March 2017

Annie Burden, Nicolas Roche, Cristiana Miglio, Elizabeth V Hillyer, Dirkje Postma, R. Brett McQueen, Ron M.C. Herings, Jetty A. Overbeek, Javaria Mona Khalid, Daniela van Eickels, Joan B. Soriano, David Price

Opri Logo White
An academic research institution striving to improve the lives of patients.
Company
Observational and Pragmatic Research Institute (registered in Singapore) 
Observational Pragmatic Research International (registered in England and Wales)
Follow Us
Contact Us
Email: 
info@opri.sg 
Tel:
(+65) 3105 1489 
Address
OPRI Singapore
22 Sin Ming Lane #06-76, Midview City 573969
OPRI UK
Warren House, Sankence, Aylsham, Norwich NR11 6UN
  • Instagram
  • Threads
  • LinkedIn
  • X
OPRI 2025 All Rights Reserved
bottom of page